Nanalysis Scientific Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NSCIF research report →
Price Chart
About the company
Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment.
- CEO
- Sean Krakiwsky
- IPO
- 2020
- Employees
- 15,299
- HQ
- Calgary, AB, CA
Get TickerSpark's AI analysis on NSCIF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $9.88M
- P/E
- -3.09
- Fwd P/E
- 4.45
- PEG
- -0.03
- P/S
- 0.35
- P/B
- 1.14
- EV/EBITDA
- 53.55
- Div Yield
- 0.00%
- Gross Margin
- 20.27%
- Op Margin
- -5.03%
- Net Margin
- -10.35%
- ROE
- -33.44%
- ROIC
- -7.54%
Latest fiscal year · YoY change
- Revenue
- $40.13M-11.8%
- Gross Profit
- $9.96M-21.8%
- Op Income
- $-3,766,000
- Net Income
- $-5,658,000+58.4%
- EPS
- $-0.05+58.3%
- OCF Growth
- +5.8%
- FCF Growth
- +11.6%
- 52W High
- $0.14
- 52W Low
- $0.07
- 50D MA
- $0.08
- 200D MA
- $0.09
- Beta
- -0.12
- RSI (14)
- 15
- Avg Volume
- 5.84K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Nanalysis reported modest Q2 revenue growth, but a much stronger improvement in adjusted EBITDA and net loss, while management said the second half should look materially better.· August 24, 2026
- Q2 revenue was C$9.722 million, up C$146 thousand or 1.5% year over year.
- Adjusted EBITDA improved to C$881 thousand, up C$1.343 million from last year’s quarter.
- Net loss narrowed to C$666 thousand, an improvement of C$1.456 million year over year.
- Product sales were pressured by the end of third-party equipment sales, while security services grew on more project work.
- Management expects stronger results in the second half, citing seasonality, a healthier pipeline, and a lower cost structure.
For the three months ended 06/30/2026, consolidated revenue was C$9.722 million, up C$146 thousand or 1.5% year over year. Product gross margin was 65% versus 61% a year ago, and security services gross margin was 12% versus 10% a year ago. Adjusted EBITDA was C$881 thousand, an increase of C$1.343 million versus the corresponding period in 2025, and net loss was C$666 thousand, an improvement of C$1.456 million year over year. Management did not provide formal next-quarter or full-year guidance, but said Q3 and the second half should be significantly better than the first half, with normal seasonality expected to help Q4.
Sean Krakiwsky struck an upbeat tone and emphasized that adjusted EBITDA is improving and is a key proxy for cash generation for the company, the bank, and the board. He said the business is moving toward better profitability as revenue grows, helped by a new cost structure and a more organic operating model. He highlighted improvements in the international dealer network, a revamped direct sales organization, ongoing product innovation, and potential licensing and recurring revenue opportunities in MRI and high-field NMR.
Heather Kury focused on the quarter’s financial improvement and the operational drivers behind it. She said revenue rose to C$9.722 million, product gross margin improved to 65% from 61%, security services gross margin improved to 12% from 10%, adjusted EBITDA reached C$881 thousand, and net loss narrowed to C$666 thousand. She attributed the gains to operational improvements, better security services performance, lower SG&A, and filing eligible investment tax credits.
There was no formal analyst Q&A, but an investor asked about near-term execution and management’s optimism. Sean responded that he expects progress over the next couple of quarters and said the company is patient but waiting for results to show up. He also addressed tariff concerns directly, saying Nanalysis is exempt from the tariffs being discussed in the media and is not affected by the U.S.-Canada trade turbulence.
The bull case is that the company is already showing a sharper profitability trend, with adjusted EBITDA and margins improving even on only modest revenue growth. Management also sounded confident that the second half will be stronger, supported by seasonality, a better cost base, a rebuilt sales organization, and new product and licensing opportunities.
The main risks are that revenue growth is still limited, product revenue declined because third-party equipment sales ended, and management is leaning on a second-half rebound rather than reporting it yet. Sean also acknowledged that the first half was weak across the instrumentation sector and that macro uncertainty delayed sales and affected the pipeline, especially earlier in the year.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 95.7%
- Shares Outstanding
- 139.41M
- Float Shares
- 133.47M
Our NSCIF coverage
Recent articles, reports, and earnings notes.
No research on NSCIF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NSCIF report →Nanalysis Scientific Corp. (NSCI:CA) Shareholder/Analyst Call Prepared Remarks Transcript
seekingalpha.com · Sep 24
Nanalysis Scientific Corp. (NSCI:CA) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 24
Nanalysis Provides Business Update Highlighting Quantum Technology Partnerships, $1Million in Non-Dilutive Non-Repayable Funding Award, Contract Wins and Corporate Activities
prnewswire.com · Jun 23
Nanalysis Announces First Quarter 2026 Results
prnewswire.com · May 20
Nanalysis Announces First Quarter 2026 Conference Call
prnewswire.com · May 13
Nanalysis Announces Board Transition and Appointment of Three New Directors
prnewswire.com · May 1
Nanalysis Scientific Corp. (NSCI:CA) Q4 2025 Earnings Call Prepared Remarks Transcript
seekingalpha.com · Apr 9
Nanalysis Announces Fourth Quarter and Full Year 2025 Results
prnewswire.com · Apr 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.